AUGX - Augmedix, Inc. Stock Price, Fair Value and News

$2.35

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

AUGX Price Action

AUGX RSI Chart

AUGX Valuation

AUGX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AUGX Fundamentals

AUGX Revenue

AUGX Earnings

AUGX Profitability

AUGX Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	48.7M	51.6M	0	0
2023	33.6M	37.0M	40.9M	44.9M
2022	24.4M	26.5M	28.8M	30.9M
2021	17.3M	18.8M	20.1M	22.2M
2020	14.7M	15.3M	15.9M	16.5M
2019	0	0	0	14.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Augmedix, Inc.

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

CEO	Mr. Emmanuel Krakaris
WEBSITE	augmedix.com
SECTOR	Healthcare
INDUSTRY	Health Information Services
EMPLOYEES	1040